

          -  Prior diagnosis of COVID-19 infection

          -  Participation in another COVID-19 prophylaxis trial within 30 days of consent

          -  Respiratory illness with new-onset fever (Temperature > 100*F) or ongoing cough or
             dyspnea within 14 days

          -  Known allergy to HCQ or chloroquine

          -  Congenital prolonged QT syndrome

          -  Current or planned use of QT prolonging drugs (e.g. procainamide, disopyramide,
             mexilitine, flecainide, propafenone, amiodarone, sotalol, cimetidine, dronedarone,
             dofetilide, levofloxacin, ciprofloxacin, moxifloxacin)

          -  End stage renal disease

          -  Pre-existing retinopathy

          -  Current or planned use of the following for treatment or prevention of COVID-19
             infection:

               -  Hydroxychloroquine (study drug) or chloroquine

               -  azithromycin
      